Literature DB >> 22144661

Difficult cases of pain and nonpain symptoms in intractable spinal infections: a case series.

Molly L Olsen1, Rachel D A Havyer, Thomas J Smith, Keith M Swetz.   

Abstract

In the modern age of advanced surgical techniques and pharmacologic management, bacterial spinal infections (SIs) can be managed (either eradicated or suppressed) in many hosts. However, the optimal management of SIs may be limited by patient comorbidities, which do not allow for surgical management, or limited by antimicrobial options due to side effects, toxicities, or emerging drug resistance. In these settings, frank and honest discussion regarding risks and benefits of treatment should be pursued, including that the SI may be a terminal illness. In this case series, we present 3 patients who had bacterial SIs whose treatments were limited by the above-mentioned factors. Furthermore, each case presented challenges regarding optimal medical management of somatic and neuropathic pain associated with the SI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22144661      PMCID: PMC4042426          DOI: 10.1177/1049909111429121

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  5 in total

Review 1.  Spinal epidural abscess.

Authors:  Rabih O Darouiche
Journal:  N Engl J Med       Date:  2006-11-09       Impact factor: 91.245

2.  Septic discitis: an important cause of back pain.

Authors:  Prakashchandra Patel; Kenneth E Olive; Koyamangalath Krishnan
Journal:  South Med J       Date:  2003-07       Impact factor: 0.954

3.  Spinal epidural abscess: a meta-analysis of 915 patients.

Authors:  E Reihsaus; H Waldbaur; W Seeling
Journal:  Neurosurg Rev       Date:  2000-12       Impact factor: 3.042

4.  Medical vs surgical management of spinal epidural abscess.

Authors:  Farhan Siddiq; Ashish Chowfin; Robert Tight; Abe E Sahmoun; Raymond A Smego
Journal:  Arch Intern Med       Date:  2004 Dec 13-27

Review 5.  Ethical decision making with end-of-life care: palliative sedation and withholding or withdrawing life-sustaining treatments.

Authors:  Molly L Olsen; Keith M Swetz; Paul S Mueller
Journal:  Mayo Clin Proc       Date:  2010-08-30       Impact factor: 7.616

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.